Daily Roundup

Macquarie Group Posts Strong Half-Year Results

Macquarie Group is having a stellar half, with net profit surging 50% to $A2,478 million for the six months ended 30 September 2026. The financial services giant's earnings per share climbed 49% to $A6.52, reflecting broad-based strength across its operations.

The company's net operating income grew 10% to $A9,568 million, driven by higher net interest and trading income alongside solid investment returns. Operating expenses rose just 1% to $A6,317 million, demonstrating disciplined cost management even as the business expanded. That efficiency translated into an annualised return on equity of 13.8%, up significantly from 9.6% in the prior year.

Behind the numbers, Macquarie's core businesses are firing on all cylinders. Assets under Management climbed 3% to $A742.9 billion, while the home loan portfolio expanded 9% to $A198.2 billion. The Banking and Financial Services division saw deposits grow 10% to $A236.2 billion, reflecting growing customer confidence. Macquarie Asset Management, the standout performer, pulled in $A15.3 billion in fresh capital from clients and contributed $A1,509 million to net profit, up 28% year-on-year.

The company's balance sheet remains fortress-like, with a CET1 ratio of 12.9%, comfortably above regulatory minimums. Management declared an interim ordinary dividend of $A3.25 per share at 35% franked, representing a 50% payout ratio. Net tangible assets per share jumped 17.34% to $A88.30, rewarding shareholders with solid value creation.

Qantas Navigates Elevated Fuel Costs with Resilient Demand

Qantas Group is holding its own despite headwinds from elevated fuel prices, with trading conditions tracking in line with full-year guidance. The airline is banking on resilient customer demand to weather the storm, with both domestic and international travel remaining robust.

The group expects Group Domestic and Group International total unit revenue to grow 8 to 10% in the first half of 2027, a solid result given the operating environment. International demand is particularly strong, bolstered by travel redirection from the Middle East, while domestic leisure travel continues to perform well. Corporate and government travel remains stable, providing a steady revenue base.

Fuel costs are the elephant in the room. Qantas expects to pay approximately $3.75 billion for fuel in the first half of 2027, with prices expected to remain elevated throughout the financial year. The group has taken a prudent approach, locking in roughly 85% of its FY27 fuel exposure through hedging, predominantly in Brent crude oil. The airline is adjusting fares and capacity as needed to offset these pressures.

On a brighter note, Qantas Loyalty is tracking well, with underlying EBIT growth expected to reach 5 to 7% in FY27. Capital expenditure is also being managed carefully, with net capex expected at the lower end of the $4.3 to $4.6 billion guidance range.

Nine Entertainment Targets Growth Across Diversified Portfolio

Nine Entertainment is positioning itself for another year of expansion in FY27, leveraging its diversified business model to drive revenue and EBITDA growth. The company's digital subscription revenue climbed 7% in the first quarter of FY27, demonstrating the strength of its content and streaming strategy.

Outdoor media is firing, with revenue expected to grow in the mid-teens during the first half of 2027. Meanwhile, Stan, the company's streaming platform, is set to deliver EBITDA growth thanks to Stan Sport and the second season of Premier League rights, which should attract and retain subscribers.

Nine is also making significant progress on its cost-reduction program. The company now targets $180 million in annualised savings by FY27, exceeding its previous estimate of $160 million. These efficiency gains should flow through to the bottom line as the company scales its operations.

Clinuvel Pharmaceuticals Emphasizes Financial Discipline and Growth Strategy

Clinuvel Pharmaceuticals' Managing Director outlined a strategic vision centred on financial discipline and targeted investment. The company highlighted its ability to self-fund its development cycles, a key strength in the competitive pharmaceutical landscape.

The company plans to pursue what it calls "concentric expansion," investing in new technologies and markets to drive future growth. Areas of focus include peptide chemistry, polymer chemistry, and clinical applications—all areas where Clinuvel sees opportunities to build competitive advantages and expand its addressable market.

Steadfast Group Discloses Notice from Pentwater Capital

Steadfast Group has received a notice from Pentwater Capital Management LP pursuant to Australian Takeovers Panel Guidance Note 20 on Equity Derivatives. The disclosure, authorised by Steadfast's Disclosure Committee, is a routine regulatory filing that keeps shareholders and the market informed of significant developments.